Clinical Trials Logo

Atrophy, Muscular clinical trials

View clinical trials related to Atrophy, Muscular.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05773469 Completed - Energy Expenditure Clinical Trials

Energy Balance in Extreme Environments: Finding the EI Limit

StOMPE
Start date: February 28, 2023
Phase:
Study type: Observational

This project is feasibility study looking at extreme exercise and possible diet intervention study to counter muscle and weight loss during a 2 person Greenland Ski Traverse in April 2023. By increasing energy intake to above the currently theoretical capacity (2.5 x RMR) the aim is to test a method to find out if there is a maximum to energy intake and whether energy deficit can be minimised; weight loss attenuated, and whether muscle can be preserved. If not, what are the likely adaptive mechanisms and use this to inform future work on dietary interventions

NCT ID: NCT01476072 Completed - Atrophy, Muscular Clinical Trials

31P MRS Ischaemic Exercise Optimisation and COPD

Start date: April 2010
Phase: Phase 1
Study type: Interventional

An MRI study to develop a reliable methodology for 31P MRS ischaemic exercise in order to obtain a consistent standard of measurement of muscle metabolism while maintaining an acceptable level of subject comfort and use optimised method to measure and compare metabolism in the biceps and quadriceps of patients with COPD-related myopathy and control subjects

NCT ID: NCT00964340 Completed - Atrophy, Muscular Clinical Trials

A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days

Start date: October 1, 2009
Phase: Phase 1
Study type: Interventional

The primary objective is to determine the pharmacokinetics, safety and tolerability of SRT2104 in healthy elderly subjects following single and 28 days dosing. The secondary objectives of the study are: 1. To contrast changes in leg muscle function following repeat doses of SRT2104 or placebo: Endurance exercise tolerance 31P MRS measures of mitochondrial oxidative capacity in the gastrocnemius muscle 2. To test for a change in the ratio of visceral to subcutaneous body fat following repeat doses of SRT2104 relative to placebo using MRI 3. To estimate any changes in insulin sensitivity (using mOGTT) following repeat doses of SRT2104 or placebo 4. To test for dose-related effects on the exploratory pharmacodynamic measures above